Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Spine

COMORBIDITY AND HEALTH RELATED QUALITY OF LIFE AT LONG-TERM AFTER BRACING FOR IDIOPATHIC SCOLIOSIS

Combined British Scoliosis Society/Nordic Spinal Deformity Society (BSS/NSDS)



Abstract

Purpose

To evaluate comorbidity and health-related quality of life in patients with idiopathic scoliosis.

Patients and methods

496 patients treated with Boston brace for idiopathic scoliosis were invited for long-term follow-up. 361 women and 29 men responded. Mean age was 39.2 (4.6) years; mean follow-up time 23.4 (4.3) years. 28 patients had been operated. All patients had radiographs at baseline, brace weaning, and follow-up, and filled in validated self-report questionnaires for evaluation of health-related quality of life.

Results

122 patients had at least one comorbid condition at follow-up. The most commonly reported diseases were: asthma, n = 14; migraine, n = 13; lower extremity disorders, n = 10; anxiety/depression, n = 9; allergy, n = 9; cardiovasular disease, n = 8; lumbar disc herniation, n = 8; neck pain or injury, n = 8; and widespread pain, n = 8. Age at bracing and at menarche, compliance, curve sizes, and the number of patients operated were not different in patients with comorbidity. Mean EQ-5D was 0.74 with comorbidity and 0.85 (normal) without (p < 0.001). Global back rating was excellent or good in 61% with comorbidity versus 78% without (p < 0.000). Fifty-seven percent versus 86% worked full-time. Those with comorbidity had lower (p < 0.001) SRS-22 scores for pain, function, self-image, and mental health, but satisfaction with bracing was not different. Final major curve size was associated only with self-image.

Conclusion

Health related quality of life and work were reduced in patients with idiopathic scoliosis reporting comorbidity at long-term.



Ethics approval: The committee for medical research ethics in the Health Region South-East in Norway and the hospital patient ombudsman approved the study.

Funding: The study was supported by grant from the Fondation Sophies Minde.